<code id='08C2DEBF49'></code><style id='08C2DEBF49'></style>
    • <acronym id='08C2DEBF49'></acronym>
      <center id='08C2DEBF49'><center id='08C2DEBF49'><tfoot id='08C2DEBF49'></tfoot></center><abbr id='08C2DEBF49'><dir id='08C2DEBF49'><tfoot id='08C2DEBF49'></tfoot><noframes id='08C2DEBF49'>

    • <optgroup id='08C2DEBF49'><strike id='08C2DEBF49'><sup id='08C2DEBF49'></sup></strike><code id='08C2DEBF49'></code></optgroup>
        1. <b id='08C2DEBF49'><label id='08C2DEBF49'><select id='08C2DEBF49'><dt id='08C2DEBF49'><span id='08C2DEBF49'></span></dt></select></label></b><u id='08C2DEBF49'></u>
          <i id='08C2DEBF49'><strike id='08C2DEBF49'><tt id='08C2DEBF49'><pre id='08C2DEBF49'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:8
          Stock exchange
          Drew Angerer/Getty Images

          Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

          On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

          advertisement

          “We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          New rules on organ donation and transplantation 'will bring chaos'
          New rules on organ donation and transplantation 'will bring chaos'

          OrgandonationpaperworkatMid-AmericaTransplantServicesinSt.Louis.WhitneyCurtis/APTheUnitedStateshadao

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          The best solution to the drug shortages problem

          AdobeDrugshortagesintheUnitedStatesareatarecordhigh.Atleast14essentialgenericcancerdrugsarecurrently